INSIGHTS ON CONTRACT PHARMA MANUFACTURING

• Fill-Finish Contract Manufacturing: Trends, Challenges, And The Future

  See why it's important to partner with a CDMO that’s investing in advanced sterile fill-finish capabilities to meet the demands of complex biologics, gene therapies, and mRNA-based products.

• Nitrosamine Testing: How To Ensure Regulatory Compliance, Product Safety

  Explore what nitrosamines are, why testing matters, and how we're able to deliver high-confidence solutions through advanced science and industry-leading expertise.

• AI For Faster, Smarter Gene Therapy Development And Manufacturing

  Here, we highlight real-world applications of AI in gene therapy, providing case studies and addressing the challenges and prerequisites for successful implementation.

• CDMO Hunger Games And The State Of Biotech With Siren Biotechnology's Nicole Paulk, Ph.D.

  Biotech leader Nicole Paulk, Ph.D., joins “Better Biopharma” to discuss Siren Biotechnology’s switch from plasmids to producer cell lines, CGT funding challenges, and the competition that determined which CDMO won Siren’s business.

• Protecting The Foundation Of Biologics With Flexible, Scalable Cell Banking

  Safeguard your cell banks with secure, compliant storage and streamlined delivery solutions that keep manufacturing on schedule and therapies moving forward.

• ATMP Development In 2025: Promise, Pressure, And The Push To Scale

  Drive the next wave of cell and gene therapy innovation by overcoming operational, funding, and regulatory challenges to deliver life-changing treatments to patients faster.

• Built For Speed: How To Deliver Without Compromise

  Ensure fast, reliable, temperature-controlled logistics with a global infrastructure designed to protect critical biologic materials and keep development programs running smoothly and on schedule.

• Development Of A Non-Standard Protein Therapeutic

  Discover how a tailored development approach transformed a complex therapeutic protein into a candidate ready for early-stage clinical trials.

• Benefits Of Outsourcing To An Integrated CDMO

  Streamlining ADC development through an integrated CDMO can reduce risk and improve quality. Discover why specialized expertise in linker chemistry and bioconjugation is key to overcoming the complexity of ADC manufacturing.

• Extractables, Leachables, And Risk: Ensuring Safety In Pharma Manufacturing

  This session is designed for teams developing new products, optimizing processes, or preparing regulatory submissions, and will provide practical tools for a better approach to E&L management.